A new at-home test to diagnose type-1 diabetes is being investigated by researchers at the Oxford Biomedical Research Centre.

With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Oxford Biomedical Research Centre is set to initiate a study into a new at-home test for diagnosing type 1 diabetes (T1D) in children. Developed by UK-based company Digostics, GTT@home is an oral ...

A home test to diagnose type 1 diabetes in children is being investigated in a UK study for the first time. Researchers at ...

There are various blood sugar monitors for those with diabetes and it is important to have regular monitoring done. While ...

THOUSANDS of Irish people are diagnosed with type 2 diabetes every year. And one in ten globally are living with the chronic ...

Europe urinalysis market was valued at $740.8 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the growing geriatric population, the prevalence of age-related diseases, the ...

Asia Pacific urinalysis market will grow by 7.7% annually with a total addressable market cap of $ 10,873.5 million over 2022-2031, driven by the growing geriatric population, the prevalence of ...